ARCHIVES

Genentech: ODAC Lacks Expertise, Impartiality; FDA: Company’s Proposal Unscientific

This article is from The Cancer Letter archive.

Vol. 37 No. 32 | August 12, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: NCAB Still Without New Appinees As Carter, Califano Delay Drags On; Keele to U. Kansas

January 19, 1979

Breast Cancer Treatment Studies Need Standard Definitions – Carbone

May 10, 1974

Rauscher Tells Flood Subcommittee How He Would Spend An Extra $50 Million-On Centers, Grants

April 12, 1974

Program Announcements For Studies On Blue Collar Workers, Children Released By DRCCA

November 5, 1982

Agricultural Pesticide Use Linked To Prostate Cancer

July 25, 2003

Older Patients Tolerate Chemo, Decline Due To Severe Toxicity

February 28, 2003